The diagnosis of Alzheimer’s disease requires careful analysis of the signs and symptoms of the individual with cognitive decline.1 The available clinical scales can measure general cognitive abilities, comparing scores against those of an average person in the same age group and demographics as the individual with subjective cognitive decline.1 With this, healthcare professionals can confirm the presence of cognitive and functional decline.1

file_download Download in HQ

Related content

The Complexities and Prospects of Dementia Care in the Future play_circle Video play_circle
The Complexities and Prospects of Dementia Care in the Future

Professor Dr. Matthew Kiernan discusses the limitations of current trial models.

04.12.2024 Alzheimer’s Disease
The Challenges and Potential of Clinical Trials in Dementia Research play_circle Video play_circle
The Challenges and Potential of Clinical Trials in Dementia Research

Professor Dr. Matthew Kiernan discusses the limitations of current trial models.

12.11.2024 Alzheimer’s Disease
image Image Stroke, migraine, AD and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021
Highlights from the Global Burden of Disease 2021 Study

Stroke, migraine, Alzheimer’s Disease and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021

25.07.2024 Alzheimer’s Disease